Treatment of multiple sclerosis with newer immune-modulating drugs
نویسندگان
چکیده
منابع مشابه
The use of immune modulating drugs for the treatment of multiple sclerosis
This review discusses the mechanisms of action of 4 immune modulating drugs currently used in the treatment of multiple sclerosis (MS), including Alemtuzumab, a humanized monoclonal antibody that functions by targeting CD52, an antigen primarily expressed on T and B lymphocytes and monocytes/macrophages, resulting in their depletion and subsequent repopulation; Dimethyl fumarate that switches c...
متن کاملImmune Rebound: Multiple Sclerosis after Treatment of Cushing’s disease
High cortisol level in endogenous Cushing’s syndrome suppresses the immune system and after treatment there may be an over activity of immune reaction leading to autoimmune diseases mostly thyroid and rheumatologic disorders. This is the second reported case of multiple sclerosis developing after treatment of Cushing’s syndrome. A 42-year old man is reported who presented with bone fracture and...
متن کاملP 125: Treatment of Multiple Sclerosis with Mesenchymal Cells Starfish
Arm grooves of star-fish have mesenchymal stem cells derived from adipose tissue cell. Widespread studies have shown that stem cells derived from adipose-derived mesenchymal stem cell from bone marrow have many similarities in terms of the ability to differentiate into a variety of tissues. Most of the animals live in warm and shallow waters and the waters of this feature is that it is low in d...
متن کاملimmune rebound: multiple sclerosis after treatment of cushing’s disease
high cortisol level in endogenous cushing’s syndrome suppresses the immune system and after treatment there may be an over activity of immune reaction leading to autoimmune diseases mostly thyroid and rheumatologic disorders. this is the second reported case of multiple sclerosis developing after treatment of cushing’s syndrome. a 42-year old man is reported who presented with bone fracture and...
متن کاملNewer Drugs in the Treatment of Hypertension
IN A PREVIOUS study it was demonstrated that hexamethonium, although a potent anticholihergic compound capable of lowering blood pressure for short periods, is not satisfactory as a single drug for the longterm treatment of severe hypertension.' While this study w-as in progress, preliminary clinical iinvestigationi of hydralazine (Apresoline) demonstrated this compound to be partially effectiv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 2002
ISSN: 0312-8008,1839-3942
DOI: 10.18773/austprescr.2002.033